Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Activation of Blood CD3+CD56+CD8+ T Cells during Pregnancy and Multiple Sclerosis.

de Andrés C, Fernández-Paredes L, Tejera-Alhambra M, Alonso B, Ramos-Medina R, Sánchez-Ramón S.

Front Immunol. 2017 Feb 23;8:196. doi: 10.3389/fimmu.2017.00196. eCollection 2017.

2.

Parasitic infection as a potential therapeutic tool against rheumatoid arthritis.

Apaer S, Tuxun T, Ma HZ, Zhang H, Aierken A, Aini A, Li YP, Lin RY, Wen H.

Exp Ther Med. 2016 Oct;12(4):2359-2366. Epub 2016 Sep 5.

3.

Synthetic glycolipid activators of natural killer T cells as immunotherapeutic agents.

Carreño LJ, Saavedra-Ávila NA, Porcelli SA.

Clin Transl Immunology. 2016 Apr 8;5(4):e69. doi: 10.1038/cti.2016.14. eCollection 2016 Apr. Review.

4.

PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis.

Qiu MK, Wang SC, Dai YX, Wang SQ, Ou JM, Quan ZW.

PLoS One. 2015 Jun 2;10(6):e0128523. doi: 10.1371/journal.pone.0128523. eCollection 2015.

5.

Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.

Van Kaer L, Wu L, Parekh VV.

Immunology. 2015 Sep;146(1):1-10. doi: 10.1111/imm.12485. Epub 2015 Jun 22. Review.

6.

NKT cells can help mediate the protective effects of 1,25-dihydroxyvitamin D3 in experimental autoimmune encephalomyelitis in mice.

Waddell A, Zhao J, Cantorna MT.

Int Immunol. 2015 May;27(5):237-44. doi: 10.1093/intimm/dxu147. Epub 2015 Jan 8.

7.

IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset.

Sag D, Krause P, Hedrick CC, Kronenberg M, Wingender G.

J Clin Invest. 2014 Sep;124(9):3725-40. doi: 10.1172/JCI72308. Epub 2014 Jul 25.

8.

Natural killer T cells in adipose tissue are activated in lean mice.

Kondo T, Toyoshima Y, Ishii Y, Kyuwa S.

Exp Anim. 2013;62(4):319-28.

9.

CD19(+) B cells confer protection against experimental cerebral malaria in semi-immune rodent model.

Bao LQ, Huy NT, Kikuchi M, Yanagi T, Senba M, Shuaibu MN, Honma K, Yui K, Hirayama K.

PLoS One. 2013 May 28;8(5):e64836. doi: 10.1371/journal.pone.0064836. Print 2013.

10.

Activation of Invariant NKT cells with glycolipid ligand α-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis.

Horikoshi M, Goto D, Segawa S, Yoshiga Y, Iwanami K, Inoue A, Tanaka Y, Matsumoto I, Sumida T.

PLoS One. 2012;7(12):e51215. doi: 10.1371/journal.pone.0051215. Epub 2012 Dec 12.

11.

Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?

Simoni Y, Diana J, Ghazarian L, Beaudoin L, Lehuen A.

Clin Exp Immunol. 2013 Jan;171(1):8-19. doi: 10.1111/j.1365-2249.2012.04625.x. Review.

12.

Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury.

Bajwa A, Huang L, Ye H, Dondeti K, Song S, Rosin DL, Lynch KR, Lobo PI, Li L, Okusa MD.

J Immunol. 2012 Sep 1;189(5):2584-96. doi: 10.4049/jimmunol.1200999. Epub 2012 Aug 1.

13.

Comparison of Invariant NKT Cells with Conventional T Cells by Using Gene Set Enrichment Analysis (GSEA).

Oh SJ, Ahn JY, Chung DH.

Immune Netw. 2011 Dec;11(6):406-11. doi: 10.4110/in.2011.11.6.406. Epub 2011 Dec 31.

Supplemental Content

Support Center